Table 4. Estimated rates of total NAD synthesis (“amidated” plus “deamidated”) in mouse tissues.
In vivo total NAD synthesis ratea | amidated route | deamidated route | NAD turnover half-lifeb | |
nmol/min/g | relative | relative % | min | |
skeletal muscle | ∼1.1 | ≧99.9 | ≤0.1 | ∼300 |
lung | ∼0.6 | ≧99.9 | ≤0.1 | ∼250 |
kidney | ∼15 | 99.9 | 0.1 | ∼30 |
brain | ∼0.9 | 99.9 | 0.1 | ∼240 |
spleen | ∼1.2 | 98.4 | 1.6 | ∼130 |
small intestine | ∼1.7 | 97.2 | 2.8 | ∼90 |
heart | ∼5.2 | 99.3 | 0.7 | ∼85 |
liver | ∼21 | 99.1 | 0.9 | ∼30 |
blood | ∼0.01 | 90.9 | 9.1 | ∼2850 |
Values are calculated by the equation (4) shown in Methods, using the in vivo total NAD synthesis rate as “v” value (assumed to equal the in vivo total NAD degradation rate), and the NAD level in each tissue (Figure 4).